← Open Payments lookup

SARAH DYCKMAN: Open Payments

NPI 1871011650 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$754 in 38 payments from 16 companies in 2025. Trend: 2023 $698 · 2024 $530 · 2025 $754

Food & beverage: $754
CompanyPaymentsAmount
GlaxoSmithKline, LLC.12$160
AstraZeneca Pharmaceuticals LP4$79
Mallinckrodt Hospital Products Inc.2$66
JAZZ PHARMACEUTICALS INC.2$60
Merck Sharp & Dohme LLC3$59
Regeneron Healthcare Solutions, Inc.3$52
Actelion Pharmaceuticals US, Inc.2$43
GENZYME CORPORATION2$36
Takeda Pharmaceuticals U.S.A., Inc.1$35
United Therapeutics Corporation1$33

Products named: NUCALA, DUPIXENT, XYWAV, ZERBAXA, TRELEGY ELLIPTA, TERLIVAZ, BREZTRI, GLASSIA.

Industry payments across OR — which companies pay providers there.